Sinsin Pharmaceutical Co. Ltd (002800) - Total Liabilities

Latest as of September 2025: ₩65.10 Billion KRW ≈ $44.12 Million USD

Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has total liabilities worth ₩65.10 Billion KRW (≈ $44.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Sinsin Pharmaceutical Co. Ltd (002800) cash flow conversion to assess how effectively this company generates cash.

Sinsin Pharmaceutical Co. Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Sinsin Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 002800 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Sinsin Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Astino Bhd KLSE:7162	Malaysia	RM56.94 Million
Roscan Gold Corp V:ROS	Canada	CA$4.87 Million
Yenher Holdings Bhd KLSE:5300	Malaysia	RM42.25 Million
BioSmart Co.Ltd KQ:038460	Korea	₩109.14 Billion
Diatreme Resources Ltd AU:DRX	Australia	AU$2.33 Million
Kingfisher PLC LSE:KGF	UK	GBX5.35 Billion
Oncoinvent ASA OL:KLDVK	USA	Nkr230.30 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Sinsin Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Sinsin Pharmaceutical Co. Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.91	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.48	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sinsin Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sinsin Pharmaceutical Co. Ltd (2016–2024)

The table below shows the annual total liabilities of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩63.61 Billion ≈ $43.11 Million	+2.07%
2023-12-31	₩62.32 Billion ≈ $42.23 Million	+1.31%
2022-12-31	₩61.52 Billion ≈ $41.69 Million	+3.59%
2021-12-31	₩59.38 Billion ≈ $40.24 Million	-4.13%
2020-12-31	₩61.94 Billion ≈ $41.98 Million	-15.01%
2019-12-31	₩72.87 Billion ≈ $49.39 Million	+36.52%
2018-12-31	₩53.38 Billion ≈ $36.18 Million	+99.66%
2017-12-31	₩26.74 Billion ≈ $18.12 Million	-22.23%
2016-12-31	₩34.38 Billion ≈ $23.30 Million	--

About Sinsin Pharmaceutical Co. Ltd

KQ:002800 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$60.25 Million

₩88.90 Billion KRW

Market Cap Rank

#21166 Global

#1328 in Korea

Share Price

₩5860.00

Change (1 day)

-1.01%

52-Week Range

₩5090.00 - ₩6630.00

All Time High

₩13396.03